EU-PEARL brings together a consortium of 36 public and private partners with a vast expertise built upon previous IMI projects in both federated research platforms and ongoing platform clinical trials.
It includes world leaders in four disease-specific areas and top experts in accelerating innovation in clinical research, healthcare and health data landscapes.
Research hospitals, experienced regulators, patient advocates and a strong industry group well experienced in developing innovative medications across many diseases areas, work together on EU-PEARL to create a novel paradigm that will entail a trusted and tested framework to conduct patient-friendly, cross-company, multi-compound clinical trials.
FUNDACIÓ HOSPITAL UNIVERSITARI
VALL D’HEBRON
INSTITUT DE RECERCA (VHIR)
PROJECT COORDINATOR
JANSSEN PHARMACEUTICA NV
(JANSSEN)
PROJECT LEADER
PROJECT CO-LEADER
EATRIS ERIC
(EATRIS)
PROJECT CO-COORDINATOR
SYNAPSE
MANAGEMENT
MEMBER OF THE EXECUTIVE COMMITTEE
